XSWX
GALE
Market cap5.26bUSD
Jun 18, Last price
83.10CHF
1D
-1.54%
1Q
-9.33%
IPO
93.26%
Name
Galenica AG
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Galenica AG, a Bern, Switzerland-based company founded in 1927, functions as a prominent healthcare service provider, operating across Switzerland and on an international scale. Its comprehensive operations are strategically divided into two primary segments: Products & Care, and Logistics & IT. Within the Products & Care division, Galenica manages an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner locations. These operate under established brand names such as Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy management, this segment is also responsible for delivering medication for at-home patient treatment, launching and distributing a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, and providing dedicated marketing and sales assistance to its healthcare industry collaborators. The Logistics & IT segment delivers a suite of specialized pre-wholesale services to pharmaceutical and other healthcare enterprises. These offerings encompass storage, efficient distribution, and debt collection. Furthermore, this division provides broader logistics and IT infrastructure, including a master data system specifically designed for the healthcare sector. It also focuses on developing sophisticated management solutions for the healthcare market and is responsible for publishing both digital and print technical information about pharmaceutical products, in addition to offering comprehensive management platforms for pharmacies.
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||